Market Place
Sourcing Support
Poxel Changes Governance Post Reorganization Filing
01 Aug 2025 //
BUSINESSWIRE
Sun Pharma Q1 Net Profit Down 20%, Revenue Up 9%
01 Aug 2025 //
BUSINESS STD
Aurobindo to Acquire Lannett Company for Rs. 2,185 Cr
01 Aug 2025 //
INDPHARMAPOST
Mounjaro measures up to Trulicity in Eli Lilly cardio trial
01 Aug 2025 //
FIERCE PHARMA
Moderna Plans to Lay Off 10% of Workforce to Cut Costs
01 Aug 2025 //
REUTERS
Bayer Adds $1.37 Billion to Roundup Litigation Reserves
01 Aug 2025 //
REUTERS
Xencor Adds Raymond Deshaies, Ph.D., to Director Board
31 Jul 2025 //
BUSINESSWIRE
Tandem Diabetes Care to Participate in Upcoming Conference
31 Jul 2025 //
BUSINESSWIRE
Guardant Health to Join Canaccord Genuity 45th Growth Conference
31 Jul 2025 //
BUSINESSWIRE
Corcept Therapeutics Reveals Q2 Financial Results and Update
31 Jul 2025 //
BUSINESSWIRE
Bio-Rad`s Q2 2025 Financial Results Released
31 Jul 2025 //
BUSINESSWIRE
Enpro Announces Regular Quarterly Dividend
31 Jul 2025 //
BUSINESSWIRE
Aptar`s Q2 2025 Results Released
31 Jul 2025 //
BUSINESSWIRE
VB Spine Debuts in Australia and New Zealand
31 Jul 2025 //
BUSINESSWIRE
Regenerex Pharma Inks Licensing Deal with Holista Colltech Ltd
31 Jul 2025 //
BUSINESSWIRE
LucyRx Acquires CerpassRx to Boost Clinical Excellence
31 Jul 2025 //
BUSINESSWIRE
iCare World USA Names Dawna Owens Strategic Partnerships Director
31 Jul 2025 //
BUSINESSWIRE
Genvira, Labskin Get £1.2M UK-Canada Award for Melanoma therapies
31 Jul 2025 //
BUSINESSWIRE
MindMed`s Q2 2025 Financial Results and Business Updates
31 Jul 2025 //
BUSINESSWIRE
Closure Systems Unveils Defender-Lok™ CRC Product Line
31 Jul 2025 //
BUSINESSWIRE
Sarepta Therapeutics Set to Reveal Q2 2025 Financial Results
31 Jul 2025 //
BUSINESSWIRE
Amylyx Pharmaceuticals` Q2 2025 Financial Results Due August 7
31 Jul 2025 //
BUSINESSWIRE
Instem Acquires All Xybion Shares from Banerjee Group LLC
31 Jul 2025 //
BUSINESSWIRE
Charles River, BioTech Social Inc. Seek Crowdfunding Partnership
31 Jul 2025 //
BUSINESSWIRE
Alnylam Pharma Q2 2025 Financial Results and Recent Progress
31 Jul 2025 //
BUSINESSWIRE
Dr. Keith Appointed as Meitheal Pharma`s Chief Medical Officer
31 Jul 2025 //
BUSINESSWIRE
Hyperfine Enrolls 1st Patients in AI-Powered MRI PRIME Study
31 Jul 2025 //
BUSINESSWIRE
Vistagen`s Q1 2026 Results and Corporate Update Call on August 7
31 Jul 2025 //
BUSINESSWIRE
Omnicell Reveals Q2 2025 Results
31 Jul 2025 //
BUSINESSWIRE
Bristol Myers Squibb`s Q2 2025 Financial Results Released
31 Jul 2025 //
BUSINESSWIRE
Natera`s Q2 Results to be Announced on August 7, 2025
31 Jul 2025 //
BUSINESSWIRE
Exact Sciences, Humana Broaden Colorectal Cancer Screening
31 Jul 2025 //
BUSINESSWIRE
Baxter`s Second-Quarter 2025 Results Released
31 Jul 2025 //
BUSINESSWIRE
Agenus to Share Corporate Update & Q2 2025 Financial Report
31 Jul 2025 //
BUSINESSWIRE
Xeris Biopharma`s Q2 2025 Financial Results Due August 7
31 Jul 2025 //
BUSINESSWIRE
BeOne Gets PRIME Designation for BGB-16673 in Macroglobulinemia
31 Jul 2025 //
BUSINESSWIRE
Aurinia Pharmaceuticals` Financial Results for H1 2025 Released
31 Jul 2025 //
BUSINESSWIRE
Compass Pathways Reveals Q2 2025 Financial Results and Highlights
31 Jul 2025 //
BUSINESSWIRE
Medacta Reports 19.8% Revenue Growth in H1 2025
31 Jul 2025 //
PHARMAWEB
Ensysce Progresses Opioid With Overdose Protection After Approval
31 Jul 2025 //
PHARMAWEB
MEDICLIN Reports Positive Interim Results for H1 2025
31 Jul 2025 //
PHARMAWEB
Bayer Upgrades Sales, Earnings Guidance for 2025
31 Jul 2025 //
PHARMAWEB
HHS to Test 340B Drug Rebates in Pilot Program
31 Jul 2025 //
FIERCE PHARMA
Trump Pressures 17 Pharmas on Most-Favored-Nation Drug Pricing
31 Jul 2025 //
FIERCE PHARMA
Merck to Cut 8% of Workforce, Laying Off 6,000
31 Jul 2025 //
FIERCE PHARMA
Prasad`s Exit Indicates More Lenient FDA for Cell, Gene Field
31 Jul 2025 //
FIERCE BIOTECH
Dexcom CEO Kevin Sayer Hands Over Reins to COO Jake Leach
31 Jul 2025 //
FIERCE BIOTECH
BMS Highlights Commercial Success Amid Clinical Setbacks
31 Jul 2025 //
FIERCE BIOTECH
Fagron Sees 11% Revenue Growth, 12% REBITDA Rise in H1 2025
31 Jul 2025 //
GLOBENEWSWIRE
Pharming Reports Q2 and H1 2025 Results, Business Update
31 Jul 2025 //
GLOBENEWSWIRE
Argenx`s Half Year 2025 Financial Results and Q2 Business Update
31 Jul 2025 //
GLOBENEWSWIRE
Ipsen Reports Strong H1 2025 Results, Upgrades Full-Year Guidance
31 Jul 2025 //
GLOBENEWSWIRE
ICPO, SBMN Expand Clinical Theranostics in Brazil
31 Jul 2025 //
GLOBENEWSWIRE
Teleflex Announces Q2 Results and 2025 Full Year Outlook
31 Jul 2025 //
GLOBENEWSWIRE
Agios Reveals Q2 2025 Financial Results and Business Update
31 Jul 2025 //
GLOBENEWSWIRE
Teleflex Declares Quarterly Dividend
31 Jul 2025 //
GLOBENEWSWIRE
Relmada Therapeutics` Q2 2025 Financial Results Due August 7
31 Jul 2025 //
GLOBENEWSWIRE
INmune Bio Inc. Announces Q2 2025 Financial Results on August 7th
31 Jul 2025 //
GLOBENEWSWIRE
Amicus Therapeutics Reveals Q2 2025 Financial Results and Updates
31 Jul 2025 //
GLOBENEWSWIRE
Atea Pharmaceuticals` Q2 2025 Results and Business Update
31 Jul 2025 //
GLOBENEWSWIRE
